Clinical Trials Browser

Phase 2 × Has results × zanidatamab × Clear all

NCT04466891 2025-09-15

HERIZON-BTC-01

Phase 2 Completed

87 enrolled 25 charts 3 FDA

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT04224272 2025-08-01

A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

Phase 2 Completed

51 enrolled 10 charts

Breast Neoplasms